Project Number GC-2013666 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2017 View Full Project Details for Phase I study of an AAVrh.10-mediated Apolipoprotein E2 Gene Delivery to the CNS for the treatment of Alzheimer's Disease in E4 Homozygotes . Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator Crystal, Ronald Principal Investigator First Name Ronald Principal Investigator Last Name Crystal Awardee Organization Weill Medical College of Cornell University Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $3,006,472 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
